Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_assertion description "[This finding, together with earlier work, strongly suggests that a major form of negative feedback inhibition of PI3K results from activated growth signalling via mammalian target of rapamycin (mTOR) and the p70 S6 kinase (S6K) - a pathway that could have consequences for the development of type 2 diabetes and tuberous sclerosis complex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_assertion evidence source_evidence_literature NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_assertion SIO_000772 15653324 NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_assertion wasDerivedFrom befree-20140225 NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_assertion wasGeneratedBy ECO_0000203 NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP485847.RAKeD4ZkFO1LKDXsf6U67EAeXiZXBIxNKnCA30rNFFBvE130_provenance.